Original Articles
1621 Long-Term Effects of Preventive Cognitive Therapy in Recurrent Depression: A 5.5-Year Follow-Up Study [CME]
[Abstract] [Full Text] [CME Activity]
1629 Risk Factors for the Development of Posttraumatic Stress Disorder Following Combat Trauma: A Semiprospective Study
1636 A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder
1645 A Randomized Controlled Study of Sequentially Applied Repetitive Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder
1652 Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder
1662 Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-d-Aspartate Antagonist
1667 Somatic Versus Cognitive Symptoms of Depression as Predictors of All-Cause Mortality and Health Status in Chronic Heart Failure
1674 Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial
1681 Current Prescription Patterns and Safety Profile of Irreversible Monoamine Oxidase Inhibitors: A Population-Based Cohort Study of Older Adults [CME]
[Abstract] [Full Text] [CME Activity]
Focus on Womens' Mental Health
1687 Women’s Mental Health: Hot Topics and Clinical Implications
1688 Interactions Between Tamoxifen and Antidepressants via Cytochrome P450 2D6
1698 Distressing Sexual Problems in United States Women Revisited: Prevalence After Accounting for Depression
1707 Leisure-Time Physical Activity in Pregnancy and Risk of Postpartum Depression: A Prospective Study in a Large National Birth Cohort
1715 Time Trends in Age at Onset of Anorexia Nervosa and Bulimia Nervosa
ASCP Corner
1722 Reconceptualizing Medication Management: Implications for Training and Clinical Practice
Letters To the Editor
1724 A Novel Mutation of the Arylsulfatase A Gene in Late-Onset Metachromatic Leukodystrophy
1725 Sudden Cardiac Death in Users of Second-Generation Antipsychotics
1726 Does Depressive State Influence Reported Attachment Status?
• Reply by
1727 The Benzodiazepine Stigma Persists
1729 Corrections
Castellvi P, Navinés R, Gutierrez F, Jiménez D, Márquez C, Subirà S, Solà R, Martín-Santos R. Pegylated interferon and ribavirin–induced depression in chronic hepatitis C: role of personality (J Clin Psychiatry 2009;70[6]:817–828)
Cutler AJ, Montgomery SA, Feifel D, Lazarus A, Åström M, Brecher M. Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study (J Clin Psychiatry 2009;70[4]:526–539)
Kryzhanovskaya LA, Robertson-Plouch CK, Xu W, Carlson JL, Merida KM, Dittmann RW.T he safety of olanzapine in adolescents with schizophrenia or bipolar I disorder: a pooled analysis of 4 clinical trials (J Clin Psychiatry 2009;70[2]:247–258)
Perahia DGS, Maina G, Thase ME, Spann ME, Wang F, Walker DJ, Detke MJ. Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial (J Clin Psychiatry 2009;70[5]:706–716)
Book Reviews
1730 Approach to the Psychiatric Patient: Case-Based Essays
1730 Psychiatry, vols 1 & 2, 3rd ed
1731 Bipolar Disorder in Later Life
Author Index
online CME Activities
e45 Diagnosis and Treatment of Bipolar Disorder in Young Patients
[Abstract]
e46 Treating Major Depression: Antidepressant Algorithms
[Abstract]
e47 Differential Diagnoses and Assessment of Depression in Elderly Patients
[Abstract]